Drug to Treat Type 2 Diabetes, Ertugliflozin, Reported to Effectively Lowers Blood Glucose Levels
insulin resistance, News, Type 2 Diabetes News
Merck (MSD), together with Pfizer, recently reported that the drug ertugliflozin is able to significantly decrease the average blood glucose levels (assessed as HbA1C) in patients with type 2 diabetes. The findings were obtained from two Phase ... Read more